- Viral Culture Test
- Nucleic acid amplification test (NAAT)
- And Anti-Biotic Test
Herpes Simplex Virus Diagnostics Market is expected to grow at a CAGR of 6.4% from 2024 to 2030, from a market size of USD 389.5 million in 2023 due to the expansion of the HSV diagnostics market. Covid-19 is the main reason for expansion, where researchers have identified the link between the herpes simplex virus and the SARS-CoV-2 virus in various studies, and a rising number of HSV infections, according to the WHO estimates that 3.7 billion people under 50 have HSV-1, and 491.5 million people aged 15-49 live with HSV-2, indicating a significant and growing population requiring diagnosis, as people become increasingly informed about the potential consequences of HSV infection, they are more likely to seek testing, driving the herpes simplex virus diagnostics market demand for diagnostics, the development of newer, more accurate HSV tests with improved sensitivity and specificity is facilitating more precise and reliable diagnoses.
Herpes Simplex Virus (HSV) Diagnostics Market Key Developments:
- In October 2023, Gilead and Assembly Biosciences established a partnership for 12 years to develop next-generation therapeutics for serious viral diseases, with an initial focus on Assembly bio’s established areas of herpes viruses, hepatitis B virus (HBV) and hepatitis D virus (HDV).
- In October 2021, United BioPharma and the Shanghai Public Health Clinical Centre collaborated with Cheng Kung University in the Department of Microbiology to study the efficacy of UB-621, a best-in-class long-acting medication for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).
Herpes Simplex Virus Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
6.4%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Herpes Simplex Virus (HSV) Diagnostics Market Dynamics
High prevalence of the virus, increasing public awareness, and advancements in rapid testing technology such as nucleic acid amplification tests (NAAT), detect the presence of the viral DNA and are highly sensitive and specific, and most commonly used tests for HSV diagnosis. However, social stigma and inconsistent reimbursement policies pose challenges. The market holds promise in emerging regions such as Asia-Pacific, and Latin America with growing healthcare infrastructure and rising disposable income, and the development of multiplex tests for multiple STIs could further increase accessibility and market growth.
North-America Got Significant Share of
Herpes Simplex Virus (HSV) Diagnostics Market Regional Analysis
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Asia-Pacific is expected to grow at the highest growth rate due to the rising prevalence, increasing health awareness among the people, rising demand for advanced medical technology, and growing disposable income in these regions allowing individuals to invest more in their health, potentially increasing demand for HSV testing, North America dominates the HSV diagnostics market due to its advanced healthcare system, high STI awareness, and cutting-edge technology. However, the market is expected to mature, with slower growth compared to emerging regions. other regions hold significant market potential due to a combination of factors like growing public awareness, increasing healthcare spending, and advancements in diagnostic technology.
Latin America
Europe
Asia Pacific
Middle East
North America
Herpes Simplex Virus Diagnostics Market Segmentation
By Test Type
By Disease Type
- HSV-I
- HSV-II
By End User
- Hospital & Clinics
- Research Institutions
- Diagnostic Laboratories
Frequently Asked Questions
The global herpes simplex virus (HSV) diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2030, from a market size of USD 389.5 million in 2023.
Abbott Laboratories (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), BD (Becton, Dickinson and Company) (US), Hologic, Inc. (US), Qiagen (Netherlands), Seegene Inc. (South Korea), Agenus Inc. (U.S.), Maruho Co., Ltd. (Japan), Sanofi (France) Norgen Biotek Corp. (Canada), Bio-Rad Laboratories, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Teco Diagnostics (U.S.), and GSK plc. (U.K.)
Asia-Pacific is the fastest growing and North America is the dominant market in HSV diagnostics.
Key Features of the Reports
- The herpes simplex virus diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Herpes Simplex Virus Diagnostics Market Introduction |
| 2.1.Global Herpes Simplex Virus Diagnostics Market - Taxonomy |
| 2.2.Global Herpes Simplex Virus Diagnostics Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.Disease Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Herpes Simplex Virus Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Herpes Simplex Virus Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Herpes Simplex Virus Diagnostics Market By Test Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Viral Culture Test |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Nucleic acid amplification test (NAAT) |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. And Anti-Biotic Test |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Herpes Simplex Virus Diagnostics Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. HSV-I |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. HSV-II |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Herpes Simplex Virus Diagnostics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospital & Clinics |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Institutions |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Laboratories |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Herpes Simplex Virus Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Herpes Simplex Virus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Viral Culture Test |
| 9.1.2.Nucleic acid amplification test (NAAT) |
| 9.1.3.And Anti-Biotic Test |
| 9.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.HSV-I |
| 9.2.2.HSV-II |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital & Clinics |
| 9.3.2.Research Institutions |
| 9.3.3.Diagnostic Laboratories |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Herpes Simplex Virus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Viral Culture Test |
| 10.1.2.Nucleic acid amplification test (NAAT) |
| 10.1.3.And Anti-Biotic Test |
| 10.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.HSV-I |
| 10.2.2.HSV-II |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital & Clinics |
| 10.3.2.Research Institutions |
| 10.3.3.Diagnostic Laboratories |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Herpes Simplex Virus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Viral Culture Test |
| 11.1.2.Nucleic acid amplification test (NAAT) |
| 11.1.3.And Anti-Biotic Test |
| 11.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.HSV-I |
| 11.2.2.HSV-II |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital & Clinics |
| 11.3.2.Research Institutions |
| 11.3.3.Diagnostic Laboratories |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Herpes Simplex Virus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Viral Culture Test |
| 12.1.2.Nucleic acid amplification test (NAAT) |
| 12.1.3.And Anti-Biotic Test |
| 12.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.HSV-I |
| 12.2.2.HSV-II |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital & Clinics |
| 12.3.2.Research Institutions |
| 12.3.3.Diagnostic Laboratories |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Herpes Simplex Virus Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Viral Culture Test |
| 13.1.2.Nucleic acid amplification test (NAAT) |
| 13.1.3.And Anti-Biotic Test |
| 13.2. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.HSV-I |
| 13.2.2.HSV-II |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital & Clinics |
| 13.3.2.Research Institutions |
| 13.3.3.Diagnostic Laboratories |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Merck KGaA (Germany) |
| 14.2.2.QIAGEN (Germany) |
| 14.2.3.Norgen Biotek Corp. (Canada) |
| 14.2.4.Hologic Inc. (U.S.) |
| 14.2.5.Bio-Rad Laboratories, Inc. (U.S.) |
| 14.2.6.Meridian Bioscience, Inc. (U.S.) |
| 14.2.7.Teco Diagnostics (U.S.) |
| 14.2.8.GSK plc. (U.K.) |
| 14.2.9.Agenus Inc. (U.S.) |
| 14.2.10.Maruho Co., Ltd. (Japan) |
| 14.2.11.Sanofi (France) |
| 14.2.12.Abbott (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Merck KGaA (Germany)
- QIAGEN (Germany)
- Norgen Biotek Corp. (Canada)
- Hologic Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Meridian Bioscience, Inc. (U.S.)
- Teco Diagnostics (U.S.)
- GSK plc. (U.K.)
- Agenus Inc. (U.S.)
- Maruho Co., Ltd. (Japan)
- Sanofi (France)
- Abbott (U.S.)
- Abcam plc. (U.K.)
- bioMérieux (France)
- Thermo Fisher Scientific, Inc. (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- DiaSorin S.p.A. (Italy)
- Quidel Corporation (U.S.)
- Luminex Corporation (U.S.)